Origin BioMed's leading drug product, Neuragen(R), is the first non-prescription topical treatment for rapid relief of diabetic and post-shingles nerve pain. Neuragen(R) is available in all leading pharmacies in Canada and the United States.
About Origin BioMed Inc.
Origin BioMed, Inc. is a privately-held Canadian consumer health products company with business operations throughout the U.S. and Canada. Headquartered in Halifax, Nova Scotia, Origin BioMed Inc. manufactures health products with the highest quality active ingredients, at therapeutic levels, with evidence of scientific or clinical efficacy since 2001. Its leading drug product, Neuragen(R), helps relieve pain caused by diabetic nerve damage. For more information, please visit: www.originbiomed.com or www.neuragen.com.
Contact: Robert Silverstein VP Operations 902-444-8696 firstname.lastname@example.org
About Red Herring
Red Herring is a global media company, which unites the world's best high technology innovators, venture investors and business decision makers in a variety of forums: a leading innovation magazine, an online daily technology news service, technology newsletters and major events for technology leaders around the globe. Red Herring provides an insider's access to the global innovation economy, featuring unparalleled insights on the eme
|SOURCE Origin BioMed Inc.|
Copyright©2009 PR Newswire.
All rights reserved